Pictet Asset Management Sa Acadia Pharmaceuticals Inc Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 1,307,540 shares of ACAD stock, worth $25.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,307,540
Previous 882,275
48.2%
Holding current value
$25.8 Million
Previous $16.6 Million
88.6%
% of portfolio
0.04%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding ACAD
# of Institutions
314Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$846 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$275 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$238 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$172 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$144 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.19B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...